Product Details for: Humira
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
40MG/0.8ML
Autoinjector
351(a)
Humira
Rx
002
Injection
Subcutaneous
40MG/0.8ML
Pre-Filled Syringe
351(a)
Humira
Rx
003
Injection
Subcutaneous
20MG/0.4ML
Pre-Filled Syringe
351(a)
Humira
Disc*
004
Injection
Subcutaneous
40MG/0.8ML
Single-Dose Vial
351(a)
Humira
Disc*
005
Injection
Subcutaneous
10MG/0.2ML
Pre-Filled Syringe
351(a)
Humira
Disc*
006
Injection
Subcutaneous
40MG/0.4ML
Pre-Filled Syringe
351(a)
Humira
Rx
007
Injection
Subcutaneous
40MG/0.4ML
Autoinjector
351(a)
Humira
Rx
008
Injection
Subcutaneous
80MG/0.8ML
Pre-Filled Syringe
351(a)
Humira
Rx
009
Injection
Subcutaneous
80MG/0.8ML
Autoinjector
351(a)
Humira
Rx
010
Injection
Subcutaneous
20MG/0.2ML
Pre-Filled Syringe
351(a)
Humira
Rx
011
Injection
Subcutaneous
10MG/0.1ML
Pre-Filled Syringe
351(a)
Humira
Rx
Proper Name
adalimumab
adalimumab
BLA Number
125057
125057
Applicant
AbbVie Inc.
AbbVie Inc.
Original Approval Date
December 31, 2002
December 31, 2002
Date of First Licensure